PT  - JOURNAL ARTICLE
AU  - Zarifyan, Alla
ED  - Mack, Michael
ED  - Reardon, Michael J.
ED  - Sorajja, Paul
ED  - Di Biase, Luigi
TI  - Percutaneous Treatment of Valvular Heart Disease, Atrial Fibrillation Examined in Various Studies
DP  - 2015 May 24
TA  - MD Conference Express
PG  - 5--7
VI  - 15
IP  - 5
4099  - http://mdc.sagepub.com/content/15/5/5.short
4100  - http://mdc.sagepub.com/content/15/5/5.full
AB  - PARTNER 1 demonstrated that patients at high risk of surgery had a similar mortality at 5 years with transcatheter versus surgical aortic valve replacement, while the CoreValve US Pivotal Trial showed that transcatheter aortic valve replacement reduced mortality at 2 years when compared with surgical aortic valve replacement. Observational data showed that patients treated with MitraClip had improvements in mitral regurgitation. The AATAC-AF study showed that catheter ablation is superior to amiodarone in treating persistent atrial fibrillation.